---
abstract: PD-0332991 is a selective inhibitor of the CDK4 6 kinases with the ability
  to block retinoblastoma Rb phosphorylation in the low nanomolar range. Here we investigate
  the role of CDK4 6 inhibition in human ovarian cancer.
authors: Konecny GE, Winterhoff B, Kolarova T, Qi J, Manivong K, Dering J, Yang G,
  Chalukya M, Wang HJ, Anderson L, Kalli KR, Finn RS, Ginther C, Jones S, Velculescu
  VE, Riehle D, Cliby WA, Randolph S, Koehler M, Hartmann LC and Slamon DJ.
cancertypes: []
contact:
  email: ~
  name: Gottfried Konecny
counts:
  biosamples: 40
  samples_acgh: 40
  samples_ccgh: 0
  samples_wes: 0
  samples_wgs: 0
external_identifiers:
- pubmed:21278246
geo_data:
  geo_json:
    coordinates:
    - -118.24
    - 34.05
    type: Point
  info:
    city: Los Angeles
    continent: North America
    country: United States
    label: Los Angeles, United States, North America
    precision: city
journal: 'Clin Cancer Res 17, 6 (2011): 1591-602.'
label: 'Konecny et al. (2011): Expression of P16 and Retinoblastoma Determines Response
  to Cdk4/6 Inhibition in Ovarian ...'
notes: ~
pmid: 21278246
title: Expression of P16 and Retinoblastoma Determines Response to Cdk4/6 Inhibition
  in Ovarian Cancer.
year: 2011
